NEUROPHARMAGEN
Abstract
Software as a service (SAAS) featuring software for analyzing, accessing, and storing information and making recommendations to users in the field of pharmacogenetics; Platform as a Service (PAAS) featuring computer platforms for analyzing, accessing, storing information and making recommendations to users in the field of pharmacogenetics; Science and technology services, namely analysis in the field of pharmacogenetics; Genetic research; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Medical and pharmacological research services; Design and development of medical technology; Design and development of computer software for use with medical technology; Pharmaceutical products development; Research laboratory analysis in the field of genetics; Scientific research in the nature of conducting clinical trials for others; Structural and functional analysis of genomes; Research in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services; Medical services; Medical diagnostic services; Medical analysis services for the treatment of persons; Genetic testing for medical purposes; Performing diagnosis of diseases; Medical analysis for the diagnosis and treatment of persons; Remote monitoring of medical data for medical diagnosis and treatment; Genetic analysis in order to increase the efficiency of treatments for patients for medical purposes; Services for the preparation of medical reports, namely, providing information to medical professionals in the form of reports in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services
Filing Date
2024-07-29